Clinical Trial Update: The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for valsartan in early stage heart failure and hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension, Congestive Heart Failure | Phase 4 | Status: COMPLETED